Wegovy Telehealth Partnerships: Novo Nordisk Expansion
“`html
Novo Nordisk Expands Direct-to-Patient Sales with Telehealth Partnerships for Wegovy
Table of Contents
What Happened?
Novo Nordisk has taken the next step in selling its drugs directly to patients by pointing them to telehealth providers that can write prescriptions for its popular obesity medication Wegovy. The company now links to select virtual providers on the NovoCare direct-to-patient pharmacy website it launched earlier this year, joining other pharma giants that have leaned into direct sales through their own online portals.
The Rise of Direct-to-Consumer Pharma Sites
These new direct-to-consumer medication sites combine telehealth access points with pharmacy fulfillment, coupons, and patient details – sometimes with exclusive cash-pay pricing. Eli Lilly launched LillyDirect in January 2024 and was followed by pfizer’s patient-facing site PfizerForAll later in the year. Partnering with telehealth companies is growing as a pharma marketing tactic even as the practice has come under scrutiny from lawmakers and health policy experts who raise concerns it may create improper relationships between drugmakers and health care providers.
Key Telehealth Partnerships
Both NovoCare and LillyDirect now point patients to two of the same telehealth providers: Form Health and 9amHealth. however, the user experience differs. NovoCare links to these providers only on its Wegovy page – not for Saxenda or diabetes medications.LillyDirect directs obesity care patients to both telehealth sites, and 9amHealth is also recommended for type 2 diabetes care.